Medifoxamine

Jump to: navigation, search
Medifoxamine
Medifoxamine.svg
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H19NO2
Molar mass257.328 g/mol
3D model (JSmol)

WikiDoc Resources for Medifoxamine

Articles

Most recent articles on Medifoxamine

Most cited articles on Medifoxamine

Review articles on Medifoxamine

Articles on Medifoxamine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Medifoxamine

Images of Medifoxamine

Photos of Medifoxamine

Podcasts & MP3s on Medifoxamine

Videos on Medifoxamine

Evidence Based Medicine

Cochrane Collaboration on Medifoxamine

Bandolier on Medifoxamine

TRIP on Medifoxamine

Clinical Trials

Ongoing Trials on Medifoxamine at Clinical Trials.gov

Trial results on Medifoxamine

Clinical Trials on Medifoxamine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Medifoxamine

NICE Guidance on Medifoxamine

NHS PRODIGY Guidance

FDA on Medifoxamine

CDC on Medifoxamine

Books

Books on Medifoxamine

News

Medifoxamine in the news

Be alerted to news on Medifoxamine

News trends on Medifoxamine

Commentary

Blogs on Medifoxamine

Definitions

Definitions of Medifoxamine

Patient Resources / Community

Patient resources on Medifoxamine

Discussion groups on Medifoxamine

Patient Handouts on Medifoxamine

Directions to Hospitals Treating Medifoxamine

Risk calculators and risk factors for Medifoxamine

Healthcare Provider Resources

Symptoms of Medifoxamine

Causes & Risk Factors for Medifoxamine

Diagnostic studies for Medifoxamine

Treatment of Medifoxamine

Continuing Medical Education (CME)

CME Programs on Medifoxamine

International

Medifoxamine en Espanol

Medifoxamine en Francais

Business

Medifoxamine in the Marketplace

Patents on Medifoxamine

Experimental / Informatics

List of terms related to Medifoxamine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medifoxamine is an antidepressant drug which inhibits the reuptake of dopamine[1] and acts as an agonist at the 5HT2A and 5HT2C receptors.[2] It is used mainly in France.[3]

References

  1. Saleh S, Turner P. Ocular hypotensive effects of medifoxamine. British Journal of Clinical Pharmacology. 1992 Sep;34(3):269-71. PMID 1389953
  2. Martin P, Lemonnier F. The role of type 2 serotonin receptors, 5-HT2A and 5-HT2C, in depressive disorders: effect of medifoxamine. (French) L'Encephale. 1994 Jul-Aug;20(4):427-35. PMID 7988407
  3. Mitchell PB. Novel French antidepressants not available in the United States. Psychopharmacology Bulletin. 1995;31(3):509-19. PMID 8668756



Linked-in.jpg